1. Home
  2. ZOM

ZOM

Zomedica Corp.

Logo Zomedica Corp.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.

Founded: 2015 Country:
United States
United States
Employees: N/A City: ANN ARBOR
Market Cap: 128.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 4.8M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.04 EPS Growth: N/A
52 Week Low/High: $0.12 - $0.24 Next Earning Date: 05-09-2024
Revenue: $25,186,000 Revenue Growth: 33.05%
Revenue Growth (this year): 36.75% Revenue Growth (next year): 14.92%

Share on Social Networks:

Stock Insider Trading Activity of Zomedica Corp. (ZOM)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
POWERS JOHNNY D ZOM Director Nov 17 '23 Buy $0.17 100,000 $16,600.00 1,850,000 SEC Form 4